Circulation Research · 2025 · 20 citations · 44 references
Life SciencesCardiologyPhysiologyMetabolic PhysiologyMitochondrial BiologyMolecular PhysiologyCardiovascular DiseaseCardiovascular Molecular PhysiologyHeart FailureMitochondrial DysfunctionMitochondrial MetabolismMitochondrial PhysiologyCardiac Mitochondrial FunctionHeart Failure Molecular MechanismsHeart Failure PhysiologyLoss-of-function AnalysisLoss-of-function VariantsMetabolic Cardiac DysfunctionMitochondrial Function In CardiomyocytesVentricular Diastolic Function
BACKGROUND: Clinical management of heart failure with preserved ejection fraction (HFpEF) is hindered by a lack of disease-modifying therapies capable of altering its distinct pathophysiology. Despite the widespread implementation of a 2-hit model of cardiometabolic HFpEF to inform precision therapy, which utilizes HFD+L-NAME (ad libitum high-fat diet and 0.5% N[ω]-nitro-L-arginine methyl ester), we observe that C57BL6/J mice exhibit less cardiac diastolic dysfunction in response to HFD+L-NAME. METHODS: Genetic strain-specific single-nucleus transcriptomic analysis identified disease-relevant genes that enrich oxidative metabolic pathways within cardiomyocytes. Because C57BL/6J mice are known to harbor a loss-of-function mutation affecting the inner mitochondrial membrane protein Nnt (nicotinamide nucleotide transhydrogenase), we established an isogenic model of Nnt loss-of-function to determine whether intact NNT is necessary for the pathological cardiac manifestations of HFD+L-NAME. Twelve-week-old mice cross-bred to isolate wild-type ( Nnt +/+ ) or loss-of-function ( Nnt − / − ) Nnt in the C57BL/6N background were challenged with HFD+L-NAME for 9 weeks (N=6–10). RESULTS: Nnt +/+ mice exhibited impaired ventricular diastolic relaxation and pathological remodeling, as assessed via noninvasive echocardiographic quantification of early diastolic pulse-wave velocity (E) to mitral annular velocity (e′) ratio (E/e′) (42.8 versus 21.5, P =1.2×10 − 10 ), E/A (early-to-late mitral inflow velocity ratio) (2.3 versus 1.4, P =4.1×10 − 2 ), diastolic stiffness (0.09 versus 0.04 mm Hg/μL, P =5.1×10 − 3 ), and myocardial fibrosis ( P =2.3×10 − 2 ). Liquid chromatography and mass spectroscopy exposed a 40.0% reduction in NAD + ( P =8.4×10 − 3 ) and a 38.8% reduction in the ratio of reduced-to-oxidized glutathione (GSH: GSSG, P =2.6×10 − 2 ) among Nnt +/+ mice after HFD+L-NAME feeding. Using single-nucleus ligand-receptor analysis, we implicate Fgf1 (fibroblast growth factor 1) as a putative NNT-dependent mediator of cardiomyocyte-to-fibroblast signaling in myocardial fibrosis. CONCLUSIONS: Together, these findings underscore the pivotal role of mitochondrial dysfunction in HFpEF pathogenesis, implicating both NNT and Fgf1 as novel therapeutic targets.
44
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin, Carrie Davis, Felix Schlesinger et al. · Bioinformatics · 2012 · 56.2K citations · Full text
The single-cell transcriptional landscape of mammalian organogenesis
Junyue Cao, Malte Spielmann, Xiaojie Qiu et al. · Nature · 2019 · 4.8K citations
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
Stefan D. Anker, Javed Butler, Gerasimos Filippatos et al. · New England Journal of Medicine · 2021 · 4.6K citations · Full text
Medicine, Cardiology, Pharmacology +14
Cells of the adult human heart
Monika Litviňuková, Carlos Talavera‐López, Henrike Maatz et al. · Nature · 2020 · 1.8K citations · Full text